在肺腺癌相关的关键铁变性基因中,多个基因素修饰的相关调节作用对肺腺癌产生影响
Ye-Chen Qi1, Hui Bai1, Si-Le Hu1
1Laboratory of Theoretical Biophysics, School of Physical Science & Technology, Inner Mongolia University, Hohhot, 010021, China.
Epigenomics
|March 21, 2024
概括
这项研究揭示了多重组素修饰如何调节肺腺癌 (LUAD) 中的基因表达. 一种新的计算方法确定了与铁灭相关基因的关键调节区域,为癌症提供了潜在的表观遗传点.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症基因组学 癌症基因组学
背景情况:
- 肺腺癌 (LUAD) 涉及复杂的基因表达失调.
- 基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因
- 了解多个HM的共同调节效应对于LUAD研究至关重要.
研究的目的:
- 为了研究多个基因组修饰对LUAD中的基因表达的共同调节效应.
- 开发和应用一种新的计算方法来量化HM协同调节.
- 在LUAD中识别关键的与铁亡相关的基因及其调节机制.
主要方法:
- 在LUAD中分析了10个基因组的ChIP-seq和RNA-seq数据.
- 开发一种创新的计算方法来量化多个HM的共同调节效应.
- 应用该方法来识别LUAD中强烈的协同调节基因和区域.
主要成果:
- 在LUAD中鉴定了9个与六个铁化相关基因相关的强烈协同调节区域.
- 观察到包括CA9,PGD,CDKN2A,PML,OTUB1和NFE2L2.2在内的基因的多种共同调节模式.
- 证明了计算方法在揭示复杂的表观遗传相互作用方面的实用性.
结论:
- 开发的定量方法有效地识别了重要的HM相关调节基因和区域.
- 这些已识别的区域代表了在LUAD和其他癌症中进行治疗干预的潜在表观遗传调节目标.
- 这种方法促进了对驱动癌症发展的表观遗传机制的理解.
关键词:
计算方法是一种计算方法.协同调节的协同调节药物敏感性 药物敏感性铁性化 (ferroptosis) 是一种基因表达的基因表达方式基质子的修改 基质子的修改肺部腺癌瘤是什么瘤微环境是一个微环境.更多相关视频
相关概念视频
02:04Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
02:23Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
02:32Histone Modification
13.3K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.3K
02:25Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K
01:23Regulation of Expression at Multiple Steps
904
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
904
01:30General Transcription Factors
5.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K